SIGA Share Price Performance
US$5.35
0.02 (0.38%)
Price US$5.35
Share Pricen/a
No recently updated narratives available.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company’s lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.